Jennifer S. Swan Esq.


Jennifer Swan is a partner at Finnegan in Palo Alto, CA. She focuses her practice on enforcing and defending patent rights for clients in the biotechnology and pharmaceutical industries, and has extensive experience in cases arising from the filing of Abbreviated New Drug Applications (ANDAs).

Jennifer has been involved in all aspects of pre-trial, trial, and post-trial proceedings in federal district courts, including D. New Jersey, D. Delaware, E.D. Texas, E.D. Pennsylvania, and N.D. Illinois. In particular, Jennifer has unique experience concerning litigation practice in N.D. California, having clerked for two different judges in the district. Additionally, she has considerable experience in appellate proceedings at the U.S. Supreme Court and at the U.S. Court of Appeals for the Federal Circuit.

Jennifer has also been involved in interference proceedings in federal district court and proceedings before the Federal Trade Commission. She lectures on the subject matter of patent law, including such topics as Hatch-Waxman litigation and the patentability of different crystalline forms of drug substances.

She is co-author of the Bloomberg Law treatise Biotechnology and the Federal Circuit.